Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1

Status

Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 94NIH 24INDUSTRY 23NETWORK 14OTHER_GOV 3UNKNOWN 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 1Pancreatic Neoplasms 1Conjunctival Intraepithelial Neoplasia 1

Interventions

Cisplatin 48Capecitabine 41Gemcitabine 33apatinib 32Oxaliplatin 32Cyclophosphamide 31Radiotherapy 29Paclitaxel 29Carboplatin 29tislelizumab 27Irinotecan 27Drug Therapy 27Fluorouracil 26Docetaxel 26Bevacizumab 23fludarabine 18Nivolumab 17pembrolizumab 16Surgical Procedures, Operative 16Exercise 16Metformin 15S 1 (combination) 14camrelizumab 13Radiation 13Pemetrexed 13Control Groups 12anlotinib 11Leucovorin 11Vinorelbine 10Standard of Care 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER_GOV × Interventional × Mitomycin × Clear all
NCT06388720 2026-04-13

IMGeS

National Cancer Center, Korea

Phase 2 Recruiting
82 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT06233877 2024-02-28

GFLIPM

Hirschfeld Oncology

Phase 2 Not yet recruiting
60 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT02199327 2017-08-08

Topical Interferon Alfa 2b and Mitomycin C in Conjunctival-Corneal Intraepithelial Neoplasia

Coordinación de Investigación en Salud, Mexico

Phase 4 Completed
18 enrolled

Conjunctival Intraepithelial Neoplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡